Format

Send to

Choose Destination
J Am Coll Cardiol. 2013 Feb 12;61(6):611-4. doi: 10.1016/j.jacc.2012.11.024.

Troponin: messenger or actor?

Author information

1
Cardiovascular Division, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA. rich.popp@gmail.com

Abstract

Cardiac troponin (cTn) is a biomarker of myocardial damage. New generations of high-sensitivity assays find circulating cTn in virtually all subjects. Multiple studies in various populations and patient groups have found higher levels of cTn to be predictive of future heart failure. The author proposes that initial myocardial damage from various mechanisms may lead to anti-cTn antibodies that participate in ongoing myocardial damage that eventually results in heart failure.

PMID:
23391193
DOI:
10.1016/j.jacc.2012.11.024
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center